Harm perceptions of e-cigarettes and other nicotine products in a UK sample.


Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
05 2019
Historique:
received: 30 05 2018
revised: 22 08 2018
accepted: 14 11 2018
pubmed: 5 1 2019
medline: 17 6 2020
entrez: 5 1 2019
Statut: ppublish

Résumé

E-cigarettes (EC) and nicotine replacement therapy (NRT) are less harmful than smoking, but misperceptions of relative harm are common. Aims were to (1) assess nicotine knowledge and perceptions of: harm of EC and NRT relative to smoking, addictiveness of EC relative to smoking, and change in harm to user if smoking replaced with EC; (2) define associations of these perceptions with respondent characteristics including nicotine knowledge; and (3) explore perceived main harms of EC and whether these differ by vaping status. Analyses were: (1) frequencies; (2) logistic regressions of perceptions of relative harm, addictiveness and change in harm onto demographics, smoking and vaping status and nicotine knowledge (attributing cancer or health risks of smoking to nicotine); and (3) frequencies and χ Participants were smokers and recent ex-smokers from one wave (September 2017) of a longitudinal online survey in the United Kingdom (n = 1720). Demographics included gender, age, smoking status, vaping status and income. Survey questions collected data on nicotine knowledge and harm perceptions of different products; the relative harm perceptions of NRT, EC and tobacco cigarettes; and perceived main harms of EC. Relative to smoking, 57.3% perceived EC and 63.4% NRT to be less harmful; 25.4% perceived EC to be less addictive; and 32.2% thought replacing smoking with EC reduced health harms a great deal. Participants were less likely to endorse these beliefs if they had never vaped, and participants who had inaccurate nicotine knowledge were less likely to endorse all these beliefs apart from the addictiveness of EC. The main concerns about EC were a lack of research (48.3%), regulation or quality control (37.8%) and harmfulness of chemicals (41.6%). Large proportions of UK smokers and ex-smokers overestimate the relative harmfulness of e-cigarettes and nicotine replacement therapy compared with smoking; misattributing smoking harms to nicotine is associated with increased misperceptions.

Sections du résumé

BACKGROUND AND AIMS
E-cigarettes (EC) and nicotine replacement therapy (NRT) are less harmful than smoking, but misperceptions of relative harm are common. Aims were to (1) assess nicotine knowledge and perceptions of: harm of EC and NRT relative to smoking, addictiveness of EC relative to smoking, and change in harm to user if smoking replaced with EC; (2) define associations of these perceptions with respondent characteristics including nicotine knowledge; and (3) explore perceived main harms of EC and whether these differ by vaping status.
DESIGN
Analyses were: (1) frequencies; (2) logistic regressions of perceptions of relative harm, addictiveness and change in harm onto demographics, smoking and vaping status and nicotine knowledge (attributing cancer or health risks of smoking to nicotine); and (3) frequencies and χ
SETTING AND PARTICIPANTS
Participants were smokers and recent ex-smokers from one wave (September 2017) of a longitudinal online survey in the United Kingdom (n = 1720).
MEASUREMENTS
Demographics included gender, age, smoking status, vaping status and income. Survey questions collected data on nicotine knowledge and harm perceptions of different products; the relative harm perceptions of NRT, EC and tobacco cigarettes; and perceived main harms of EC.
FINDINGS
Relative to smoking, 57.3% perceived EC and 63.4% NRT to be less harmful; 25.4% perceived EC to be less addictive; and 32.2% thought replacing smoking with EC reduced health harms a great deal. Participants were less likely to endorse these beliefs if they had never vaped, and participants who had inaccurate nicotine knowledge were less likely to endorse all these beliefs apart from the addictiveness of EC. The main concerns about EC were a lack of research (48.3%), regulation or quality control (37.8%) and harmfulness of chemicals (41.6%).
CONCLUSIONS
Large proportions of UK smokers and ex-smokers overestimate the relative harmfulness of e-cigarettes and nicotine replacement therapy compared with smoking; misattributing smoking harms to nicotine is associated with increased misperceptions.

Identifiants

pubmed: 30609154
doi: 10.1111/add.14502
pmc: PMC6491935
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

879-888

Subventions

Organisme : Medical Research Council
ID : MR/K023195/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C57277/A23884
Pays : United Kingdom
Organisme : United Kingdom Clinical Research Collaboration
ID : MR/K023195/1
Pays : International
Organisme : Cancer Research UK
ID : C52999/A21496
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

Références

Tob Control. 2006 Jun;15 Suppl 3:iii65-70
pubmed: 16754949
Drug Alcohol Depend. 2015 Dec 1;157:106-11
pubmed: 26507173
Harm Reduct J. 2011 Aug 23;8:21
pubmed: 21859499
Am J Prev Med. 2017 Mar;52(3):339-346
pubmed: 27890516
Addiction. 2012 Nov;107(11):2037-42
pubmed: 22632274
Nicotine Tob Res. 2009 Sep;11(9):1076-82
pubmed: 19571249
Public Health. 2017 Aug;149:45-48
pubmed: 28531448
Tob Control. 2017 Mar;26(e1):e49-e58
pubmed: 27625408
Addiction. 2019 May;114(5):879-888
pubmed: 30609154
BMC Public Health. 2011 Jun 18;11:479
pubmed: 21682915
Am J Prev Med. 2017 Mar;52(3):331-338
pubmed: 28341303
Lancet. 2015 Sep 26;386(10000):1237
pubmed: 26338257
Ann Intern Med. 2017 Mar 21;166(6):390-400
pubmed: 28166548
BMJ. 2014 Nov 26;349:2014.7.0264rep
pubmed: 25428425

Auteurs

Samara Wilson (S)

Addictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Timea Partos (T)

Addictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Ann McNeill (A)

Addictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
UK Centre for Tobacco and Alcohol Studies, UK.

Leonie S Brose (LS)

Addictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
UK Centre for Tobacco and Alcohol Studies, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH